The Value of Self-Care in Public Health: Insights and Implications for Europe

By Rene Pretorius

July 2, 2025

Summary
Self-care in public health is a critical pillar of public health in Europe. It enables individuals to manage minor ailments independently while easing pressure on healthcare systems. By using non-prescription medicines, devices, and supplements, self-care cuts costs, saves time, and boosts productivity. Evidence shows that the value of self-care in public health amounts to annual savings of €36 billion and averted productivity losses of €10 billion.

Key Insights
Reported study findings highlight self-care’s economic and social value. Europe avoids €36 billion yearly by managing 1.2 billion minor health issues through self-care. This includes €26 billion in medical expenses and €10 billion in productivity losses. Self-care also reduces GP workloads. It equals needing 120,000 extra doctors or 2.4 more hours daily for current practitioners. Consumer behavior is shifting toward prevention. 84% take preventive measures, and 67% spend over €21 monthly on health aids.

Background Context
Research shows self-care’s role in tackling healthcare challenges. The AESGP notes it empowers individuals with low-cost solutions for minor ailments. EU eHealth initiatives improve access to electronic records. The eHealth score reached 83% in 2024, supporting self-care goals.

Implications
For health economics, self-care offers a scalable, cost-effective solution. It helps strained systems as populations age and chronic diseases rise. Stronger policies could optimize resources, letting providers focus on complex cases. Public health efforts can align with preventive trends, reducing reliance on costly interventions. Barriers like uneven regulations and education gaps may limit uptake. Future steps include digital health tools to enhance self-care, matching EU digital goals.

Reference url

Recent Posts

Dutch Pharmacoeconomic Redesign
         

Dutch Pharmacoeconomic Redesign: Streamlined Structure and Enhanced Transparency for Drug Assessment

🌟 Are you ready for a transformation in pharmacoeconomic assessments?

The Dutch National Health Care Institute is set to unveil its **Pharmacoeconomic Redesign** on September 1, 2025, introducing a refined framework for evaluating drug reimbursement in the Netherlands. This innovative approach emphasizes clarity, transparency, and methodological rigor, ensuring more informed decisions in healthcare.

Dive into the article to discover how these changes will impact market access and elevate standards in health economics!

#SyenzaNews #HealthEconomics #MarketAccess

health technology assessment
       

Global Health Technology Assessment: Navigating NICE’s Role and Challenges in Low-Resource Settings

🌍 Are we truly ready to adapt global health technology assessments to local realities?

The latest article from NICE explores how their evidence-based health policy initiatives are shaping access and value for healthcare systems in lower and middle-income countries. However, it raises critical questions about the adaptability of their methods amidst diverse sociopolitical landscapes.

Jump into the complexities of health technology assessments and the need for localized solutions.

#SyenzaNews #HealthEconomics #GlobalHealth #HealthcarePolicy

AI medical imaging barriers
       

Facilitators and Barriers in AI Medical Imaging Implementation: A Systematic Review

🚀 Are we ready to unlock the full potential of AI in medical imaging?

Integrating AI into clinical workflows is a transformative opportunity, yet it’s fraught with challenges—from technological reliability to legal concerns. This insightful article explores critical barriers to implementation and presents actionable strategies to facilitate smooth adoption in healthcare settings.

Dive into the key findings and discover how to navigate these challenges for better patient outcomes.

Read more in the full analysis!

#SyenzaNews #AIinHealthcare #HealthTech #Innovation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

JOIN NEWSLETTER

© 2025 Syenza™. All rights reserved.